Manila Times Business
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations
Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associa
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
TIMEX GROUP TAKES FULL OWNERSHIP OF DANIEL WELLINGTON
5h ago
Innoscience Secures Removal of Court-Enjoined Infineon GaN Products from Display at electronica China 2026
5h ago
Elis continues to expand its network in Brazil with the acquisition of ServBrazil
5h ago
Aedifica NV/SA: Publication relating to a transparency notification
5h ago